The Pharmaceutical Market: Croatia

Date: January 31, 2013
Pages: 86
Price:
US$ 1,295.00
License [?]:
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PF66F9D549BEN
Leaflet:

Download PDF Leaflet

The Pharmaceutical Market: Croatia
OVERVIEW OF THE PHARMACEUTICAL MARKET IN CROATIA

The Croatian pharmaceutical market continues to pose a challenging environment to domestic and international drugmakers. The economy is expected to contract in 2012 with weak growth returning in 2013 on the anticipation of capital inflows from the EU. The implementation of a clawback tax at the start of the year will increase pricing pressu r es. VAT rises and inflation suggest growth seen in 2012 will not be due to increased drug consumption . We forecast weak growth in pharmaceutical market for the next decade owing to the prevailing economic conditions in Europe. Healthcare and medical devices spending is projected to rise significantly over the next 10 years owing to a rapidly aging population . Even after EU accession next year, we continue to believe the country will represent a modest opportunity for foreign firms.

Headline Expenditure Projections

Pharmaceuticals: HRK7.38bn (US$1.38bn) in 2011 to HRK7.55bn (US$1.39bn) in 2012; 2.2% in local currency and 0.1% in US dollar terms. Forecast up from Q4 12 due to analyst intervention.

Healthcare: HRK25.56bn (US$4.78bn) in 2011 to HRK25.34bn (US$4.64bn) in 2012; -0.9% in local currency and -2.9% in US dollar terms. Forecast broadly unchanged since Q4 12 .

Medical devices: HRK1.41bn (US$264mn) in 2011 to HRK1.39bn (US$255mn) in 2012; -1.3% in local currency and -3.3% in US dollar terms. Forecast broadly unchanged since Q4 12 .

Competitive Landscape

The Competitive Landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
EXECUTIVE SUMMARY

SWOT ANALYSIS

      Croatia Pharmaceuticals Industry SWOT
      Croatia Political SWOT
      Croatia Economic SWOT
      Croatia Business Environment SWOT

PHARMACEUTICAL RISK/REWARD RATINGS

      Table: Central And Eastern Europe Risk/Reward Ratings, Q113
      Rewards
      Risks

CROATIA – MARKET SUMMARY

REGULATORY REGIME

      Pharmaceutical Advertising
      Intellectual Property Regime
      Pricing Regime
      Reimbursement Regime
      OTC Regulations

INDUSTRY TRENDS AND DEVELOPMENTS

      Epidemiology
      Healthcare Provision
      Healthcare Expenditure
      Table: Reimbursed Drug Expenditure By HZZO (HRK) - Equivalent to Final Consumer Prices
      Table: State Budget for Healthcare (HRKbn)
      Healthcare Reform
      Clinical Trials
      Medical Devices

INDUSTRY FORECAST SCENARIO

  Overall Market Forecast
      Table: Croatia Pharmaceutical Sales, Historical Data And Forecasts
      Table: Reimbursed Drug Expenditure By HZZO (HRK) - Equivalent To Final Consumer Prices
  Key Growth Factors – Industry
      Table: Croatia Healthcare Expenditure Trends, Historical Data And Forecasts
      Table: Croatia Government Healthcare Expenditure Trends, Historical Data And Forecasts
      Table: Croatia Private Healthcare Expenditure Trends, Historical Data And Forecasts
  Economic Outlook
      Table: Croatia - Economic Activity
  Prescription Drug Market Forecast
      Table: Croatia Prescription Drug Market Indicators, Historical Data And Forecasts
  Patented Drug Market Forecast
      Table: Croatia Patented Drug Market Indicators, Historical Data And Forecasts
  Generic Drug Market Forecast
      Table: Croatia Generics Drug Market Indicators, Historical Data And Forecasts
  OTC Medicine Market Forecast
      Table: Croatia Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts
  Pharmaceutical Trade Forecast
      Table: Croatia Pharmaceutical Trade Data And Forecasts (US$mn)
      Table: Croatia Pharmaceutical Trade Data And Forecasts (HRKmn)
  Medical Device Market Forecast
      Table: Medical Devices Sales Indicators 2008-2016
  Other Healthcare Forecasts
  Key Risks To BMI’s Forecast Scenario

COMPETITIVE LANDSCAPE

  Pharmaceutical Industry
      Table: Top-10 Medicines By Value Sales
  Domestic Pharmaceutical Industry
      Table: Croatian Pharmaceutical Manufacturers
  Foreign Pharmaceutical Industry
      Company Activity
      Pharmaceutical Wholesale
      Pharmaceutical Retail

COMPANY PROFILES

  Local Company Profiles
      PLIVA (Teva Pharmaceuticals)
      Belupo
      Jadran Galenski Laboratorij
  Foreign Company Profiles
      GlaxoSmithKline
      Pfizer
      Sanofi
      Novartis
      Merck & Co
      Krka

DEMOGRAPHIC DATA

      Table: Population By Age Group, 1990-2020 (‘000)
      Table: Population By Age Group, 1990-2020 (% of total)
      Table: Key Population Ratios, 1990-2020
      Table: Rural/Urban Population Split, 1990-2020

GLOSSARY

BMI METHODOLOGY

      How We Generate Our Pharmaceutical Industry Forecasts
      Risk/Reward Ratings Methodology
      Ratings Overview
      Table: Pharmaceutical Business Environment Indicators
      Weighting
      Table: Weighting Of Components
Skip to top


The Pharmaceutical Market: China US$ 1,295.00 Jan, 2013 · 118 pages
The Pharmaceutical Market: Colombia US$ 1,295.00 Jan, 2013 · 114 pages
The Pharmaceutical Market: Cuba US$ 1,295.00 Mar, 2013
The Pharmaceutical Market: Czech Republic US$ 1,295.00 Jan, 2013 · 90 pages
The Pharmaceutical Market: Denmark US$ 1,295.00 Mar, 2013

Ask Your Question

The Pharmaceutical Market: Croatia
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: